BG42837A3 - Method for preparing immunoglobulin derivatives of vinka alkaloides - Google Patents
Method for preparing immunoglobulin derivatives of vinka alkaloidesInfo
- Publication number
- BG42837A3 BG42837A3 BG064893A BG6489384A BG42837A3 BG 42837 A3 BG42837 A3 BG 42837A3 BG 064893 A BG064893 A BG 064893A BG 6489384 A BG6489384 A BG 6489384A BG 42837 A3 BG42837 A3 BG 42837A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkaloides
- vinka
- derivatives
- immunoglobulin derivatives
- preparing immunoglobulin
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title abstract 2
- 102000018358 immunoglobulin Human genes 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229940122803 Vinca alkaloid Drugs 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8308857 | 1983-03-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG42837A3 true BG42837A3 (en) | 1988-02-15 |
Family
ID=10540516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG064893A BG42837A3 (en) | 1983-03-30 | 1984-03-29 | Method for preparing immunoglobulin derivatives of vinka alkaloides |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4845200A (de) |
| EP (1) | EP0121388B1 (de) |
| JP (1) | JPS59190924A (de) |
| KR (1) | KR890002634B1 (de) |
| AT (1) | ATE53496T1 (de) |
| AU (1) | AU570963B2 (de) |
| BG (1) | BG42837A3 (de) |
| CA (1) | CA1210696A (de) |
| DE (1) | DE3482444D1 (de) |
| DK (1) | DK167884A (de) |
| EG (1) | EG16175A (de) |
| ES (1) | ES531081A0 (de) |
| FI (1) | FI80383C (de) |
| GB (1) | GB2137210B (de) |
| GR (1) | GR79899B (de) |
| HU (1) | HU191647B (de) |
| IE (1) | IE57218B1 (de) |
| IL (1) | IL71366A (de) |
| NZ (1) | NZ207675A (de) |
| PH (1) | PH23222A (de) |
| PL (1) | PL144887B1 (de) |
| PT (1) | PT78322B (de) |
| SU (1) | SU1362404A3 (de) |
| ZA (1) | ZA842347B (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU86157A1 (fr) * | 1985-11-12 | 1987-06-26 | Omnichem Sa | Nouveau procede de fabrication de conjugues de la vinblastine et de ses derives |
| US4667030A (en) * | 1985-06-17 | 1987-05-19 | Eli Lilly And Company | Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids |
| US4675400A (en) * | 1985-06-17 | 1987-06-23 | Eli Lilly And Company | Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| FI860456A (fi) * | 1985-07-16 | 1987-01-17 | Huhtamaeki Oy Laeaeketehdas Le | Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning. |
| EP0226418B1 (de) * | 1985-12-06 | 1992-05-27 | Cetus Oncology Corporation | Anti-Immuntoxine gegen menschlichen Eierstockkrebs und Verfahren zu deren Verwendung |
| CA1289880C (en) * | 1985-12-06 | 1991-10-01 | Jeffrey L. Winkelhake | Anti-human ovarian cancer immunotoxins and methods of use thereof |
| EP0232693A3 (de) * | 1985-12-16 | 1988-04-06 | La Region Wallonne | Konjugate des Vinblastins und seiner Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| US4801688A (en) * | 1986-05-27 | 1989-01-31 | Eli Lilly And Company | Hydrazone immunoglobulin conjugates |
| ZA873600B (en) * | 1986-05-27 | 1988-12-28 | Lilly Co Eli | Immunoglobulin conjugates |
| US4994558A (en) * | 1986-12-24 | 1991-02-19 | Eli Lilly And Company | Immunoglobulin conjugates |
| RU1787160C (ru) * | 1986-12-24 | 1993-01-07 | Эли Лилли Энд Компани | Способ получени иммуноглобулинового конъюгата |
| US4814438A (en) * | 1986-12-24 | 1989-03-21 | Eli Lilly And Company | Immunoglobulin conjugates of 2',2'-difluronucleosides |
| ZA89524B (en) * | 1988-01-27 | 1990-09-26 | Lilly Co Eli | Antibody conjugates |
| FR2626882B1 (fr) * | 1988-02-08 | 1991-11-08 | Ire Celltarg Sa | Conjugues de derives de vinca comportant une chaine detergente en position c-3 |
| IT1219874B (it) * | 1988-03-18 | 1990-05-24 | Fidia Farmaceutici | Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche |
| US5094849A (en) * | 1988-08-08 | 1992-03-10 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers |
| US5144012A (en) * | 1988-08-08 | 1992-09-01 | Eli Lilly And Company | Cytotoxic drug conjugates |
| US5006652A (en) * | 1988-08-08 | 1991-04-09 | Eli Lilly And Company | Intermediates for antibody-vinca drug conjugates |
| US5028697A (en) * | 1988-08-08 | 1991-07-02 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers |
| US5010176A (en) * | 1988-11-10 | 1991-04-23 | Eli Lilly And Company | Antibody-drug conjugates |
| DE4122210C2 (de) * | 1991-07-04 | 1999-04-01 | Deutsches Krebsforsch | Konjugate aus tumoraktiver Verbindung und Serumalbumin sowie Verfahren zu deren Herstellung und ihre Verwendung |
| US5879656A (en) * | 1993-10-26 | 1999-03-09 | Thomas Jefferson University | Methods of treating metastatic colorectal cancer with ST receptor binding compounds |
| US7097839B1 (en) | 1993-10-26 | 2006-08-29 | Thomas Jefferson University | ST receptor binding compounds and methods of using the same |
| CN110790777B (zh) * | 2019-10-24 | 2021-05-25 | 广州白云山汉方现代药业有限公司 | 一种长春新碱类化合物杂质及其制备方法与应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4045420A (en) * | 1973-05-29 | 1977-08-30 | Syva Company | Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds polypeptide and derivatives thereof |
| US4026879A (en) * | 1976-03-23 | 1977-05-31 | Hoffmann-La Roche Inc. | Antigen-containing propranolol derivatives |
| US4069105A (en) * | 1977-03-03 | 1978-01-17 | Syva Company | Lidocaine antigens and antibodies |
| US4243654A (en) * | 1978-09-11 | 1981-01-06 | Syva Company | Oxazepam derivatives for immunoassay reagents |
| US4223013A (en) * | 1978-12-29 | 1980-09-16 | Syva Company | Amitriptyline conjugates to antigenic proteins and enzymes |
| US4315851A (en) * | 1978-12-29 | 1982-02-16 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition having antitumor activity |
| FI820020L (fi) * | 1981-01-12 | 1982-07-13 | Lilly Industries Ltd | Immunoglobulinkonjugater |
| FR2516794B1 (fr) * | 1981-11-20 | 1985-10-25 | Sanofi Sa | Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique |
| JPS59116229A (ja) * | 1982-12-24 | 1984-07-05 | Teijin Ltd | 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法 |
| EP0123441B1 (de) * | 1983-03-30 | 1990-10-03 | Lilly Industries Limited | Vincaleukoblastin-Derivate |
-
1984
- 1984-03-26 EP EP84302004A patent/EP0121388B1/de not_active Expired - Lifetime
- 1984-03-26 DK DK167884A patent/DK167884A/da not_active IP Right Cessation
- 1984-03-26 AT AT84302004T patent/ATE53496T1/de not_active IP Right Cessation
- 1984-03-26 GB GB08407766A patent/GB2137210B/en not_active Expired
- 1984-03-26 GR GR74217A patent/GR79899B/el unknown
- 1984-03-26 DE DE8484302004T patent/DE3482444D1/de not_active Expired - Fee Related
- 1984-03-27 AU AU26143/84A patent/AU570963B2/en not_active Ceased
- 1984-03-27 CA CA000450616A patent/CA1210696A/en not_active Expired
- 1984-03-27 IL IL71366A patent/IL71366A/xx unknown
- 1984-03-27 PT PT78322A patent/PT78322B/pt not_active IP Right Cessation
- 1984-03-28 NZ NZ207675A patent/NZ207675A/en unknown
- 1984-03-28 PH PH30460A patent/PH23222A/en unknown
- 1984-03-28 EG EG202/84A patent/EG16175A/xx active
- 1984-03-29 ZA ZA842347A patent/ZA842347B/xx unknown
- 1984-03-29 HU HU841259A patent/HU191647B/hu not_active IP Right Cessation
- 1984-03-29 ES ES531081A patent/ES531081A0/es active Granted
- 1984-03-29 SU SU843721031A patent/SU1362404A3/ru active
- 1984-03-29 BG BG064893A patent/BG42837A3/xx unknown
- 1984-03-29 FI FI841260A patent/FI80383C/fi not_active IP Right Cessation
- 1984-03-29 PL PL1984246931A patent/PL144887B1/pl unknown
- 1984-03-29 IE IE772/84A patent/IE57218B1/xx unknown
- 1984-03-30 KR KR1019840001690A patent/KR890002634B1/ko not_active IP Right Cessation
- 1984-03-30 JP JP59063140A patent/JPS59190924A/ja active Pending
-
1986
- 1986-06-23 US US06/877,598 patent/US4845200A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG42837A3 (en) | Method for preparing immunoglobulin derivatives of vinka alkaloides | |
| FI875533A0 (fi) | Insulinpreparat foer non-parenteral dosering. | |
| ES8706965A1 (es) | Un metodo de formacion de un conjugado de proteina y quelato metalico | |
| ES8801546A1 (es) | Un procedimiento para la preparacion de compuesto de 2,2-difluoronucleosidos. | |
| RU93051543A (ru) | Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей | |
| BG44538A3 (en) | Method for preparing salts of 5- metoxy- 2- big bracket [(4- metoxy- 3, 5- dimethyl- 2- pyridinyl)- methyl] sulphonyl- 1h- benzimidazol | |
| NO931635L (no) | Fremgangsmaate for fremstilling av kinazolin-derivater | |
| EP0161606A3 (en) | Drug, and methods of preparing and using it for treatment of tumors | |
| NO875378L (no) | Fremgangsmaate for fremstilling av granulocyttstimulerendefaktor (polypeptidderivater). | |
| SE8000435L (sv) | N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning | |
| GB8824869D0 (en) | Synthetic antibody | |
| BG32269A3 (en) | Method for obtaining derivatives of thiazolidine- (thazin-) carbonic acides | |
| NZ237688A (en) | Antibody-cytotoxic immunoconjugate-containing compositions and cancer treatment | |
| RU93042874A (ru) | Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии | |
| BG42677A3 (en) | Method for preparing of 6- alpha- methylcorticoides | |
| BG44379A3 (en) | Method for preparing of 9- chlor- 1, 5- benzothiazepine derivatives | |
| DE3861494D1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
| ATE36957T1 (de) | N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung. | |
| FI870416A (fi) | Terapeutiskt anvaendbara (gem-heterocyklodimetanamin n,n')platinakomplex och deras framstaellning. | |
| DE3879709D1 (de) | Platin-arzneimittel. | |
| IT8367899A0 (it) | Composizione per la cura dei tumori maligni in particolare sugli animali | |
| IT8619249A0 (it) | Kit per la determinazione dell'attivita' proliferativa nei tumori umani. | |
| RU93034452A (ru) | Производные хиназолинов для усиления противоопухолевой активности, способ их получения, способ лечения и фармацевтическая композиция | |
| DE3373907D1 (en) | N-acyl derivatives of dipeptides, their manufacture and use in treating diseases, and means therefor | |
| BG36498A3 (en) | Method for preparing indolysinic derivatives |